111 related articles for article (PubMed ID: 2521571)
1. Combined 5-fluorouracil and floxuridine administered as a 14-day infusion. A phase I study.
Anderson N; Lokich J; Bern M; Wallach S; Moore C; Williams D; Umprayn V
Cancer; 1989 Mar; 63(5):825-7. PubMed ID: 2521571
[TBL] [Abstract][Full Text] [Related]
2. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL
Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
[TBL] [Abstract][Full Text] [Related]
3. A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulation.
Anderson N; Lokich J; Bern M; Wallach S; Moore C; Williams D
Cancer; 1989 Jan; 63(2):233-7. PubMed ID: 2521296
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluorouracil and methotrexate administered simultaneously as a continuous infusion. A phase I study.
Lokich JJ; Phillips D; Green R; Paul S; Sonneborn H; Zipoli TE; Curt G
Cancer; 1985 Nov; 56(10):2395-8. PubMed ID: 4042072
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide, methotrexate, and 5-fluorouracil in a three-drug admixture. Phase I trial of 14-day continuous ambulatory infusion.
Lokich J; Bern M; Anderson N; Wallach S; Moore C; Beauchamp K; Williams D
Cancer; 1989 Mar; 63(5):822-4. PubMed ID: 2914289
[TBL] [Abstract][Full Text] [Related]
6. Combined floxuridine and cisplatin in a fourteen day infusion. Phase I study.
Lokich J; Anderson N; Bern M; Wallach S; Moore C; Williams D; Umprain V
Cancer; 1988 Dec; 62(11):2309-12. PubMed ID: 2972354
[TBL] [Abstract][Full Text] [Related]
7. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial.
Lévi FA; Zidani R; Vannetzel JM; Perpoint B; Focan C; Faggiuolo R; Chollet P; Garufi C; Itzhaki M; Dogliotti L
J Natl Cancer Inst; 1994 Nov; 86(21):1608-17. PubMed ID: 7932825
[TBL] [Abstract][Full Text] [Related]
8. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma.
Kemeny N; Cohen A; Bertino JR; Sigurdson ER; Botet J; Oderman P
Cancer; 1990 Jun; 65(11):2446-50. PubMed ID: 2140070
[TBL] [Abstract][Full Text] [Related]
9. Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer.
Stagg RJ; Venook AP; Chase JL; Lewis BJ; Warren RS; Roh M; Mulvihill SJ; Grobman BJ; Rayner AA; Hohn DC
J Natl Cancer Inst; 1991 Mar; 83(6):423-8. PubMed ID: 1825674
[TBL] [Abstract][Full Text] [Related]
10. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
11. Infusion of floxuridine plus etoposide plus cisplatin in human malignancies.
Lokich J; Moore C; Anderson N; Bern M
Eur J Cancer; 1991; 27(12):1593-6. PubMed ID: 1838261
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of 5-day continuous infusion fluorodeoxyuridine and high-dose folinic acid with oral hydroxyurea.
Raschko JW; Akman SA; Leong LA; Margolin KA; Morgan RJ; Newman E; Somlo G; Ahn C; Doroshow JH
Cancer Chemother Pharmacol; 1994; 35(2):161-4. PubMed ID: 7987994
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of continuous venous infusion of floxuridine (5-FUDR) chemotherapy.
Lokich JJ; Sonneborn H; Paul S; Zipoli T
Cancer Treat Rep; 1983 Sep; 67(9):791-3. PubMed ID: 6224555
[TBL] [Abstract][Full Text] [Related]
14. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
Greenblatt MS; Mangalik A; Ferguson J; Elias L
Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
[TBL] [Abstract][Full Text] [Related]
15. Chronomodulated 5-day infusion of floxuridine and L-folinic acid in patients with advanced malignancies: a feasibility and tolerability study.
Garufi C; Lévi F; Giunta S; Aschelter A; Pace R; Nisticò C; Terzoli E
J Infus Chemother; 1995; 5(3 Suppl 1):134-7. PubMed ID: 8528973
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
Wadler S; Atkins M; Karp D; Neuberg D; Haynes H; Dutcher JP
Cancer J Sci Am; 1998; 4(4):261-8. PubMed ID: 9689985
[TBL] [Abstract][Full Text] [Related]
17. A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
Wong JY; Shibata S; Williams LE; Kwok CS; Liu A; Chu DZ; Yamauchi DM; Wilczynski S; Ikle DN; Wu AM; Yazaki PJ; Shively JE; Doroshow JH; Raubitschek AA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5842-52. PubMed ID: 14676105
[TBL] [Abstract][Full Text] [Related]
18. A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies.
Eder JP; Garcia-Carbonero R; Clark JW; Supko JG; Puchalski TA; Ryan DP; Deluca P; Wozniak A; Campbell A; Rothermel J; LoRusso P
Invest New Drugs; 2004 Apr; 22(2):139-50. PubMed ID: 14739662
[TBL] [Abstract][Full Text] [Related]
19. Phase I clinical trial with floxuridine and high-dose continuous infusion of leucovorin calcium.
Levin RD; Gordon JH; Simonich W; Mellijor A; Sanchez R; Williams RM
J Clin Oncol; 1991 Jan; 9(1):94-9. PubMed ID: 1824639
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine riboside: optimization of 6-methylmercaptopurine riboside dose and schedule through biochemical analysis of sequential tumor biopsy specimens.
O'Dwyer PJ; Hudes GR; Colofiore J; Walczak J; Hoffman J; LaCreta FP; Comis RL; Martin DS; Ozols RF
J Natl Cancer Inst; 1991 Sep; 83(17):1235-40. PubMed ID: 1714507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
